oncology
Risk Factors

MOGA advises HBV testing before cancer therapy

Routine testing of cancer patients for hepatitis B (HBV) before starting treatment is one of the key recommendations in new guidelines released by the Medical Oncology Group of Australia (MOGA). An Australian consensus statement has been developed with the aim of simplifying the approach to testing and prophylaxis for HBV during cancer therapy. “Hepatitis B ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic